
- Pharmaceutical Technology-09-02-2013
- Volume 37
- Issue 9
XstalBio Introduces CentuRecon
CentuRecon enables dry formulations of therapeutic proteins to quickly be prepared for injection at high concentration.
CentuRecon, a patented reconstitution technology, decreases the preparation time of high concentration protein solutions from dry powder formulations and makes delivery faster and safer, according to the company. CentuRecon enables dry formulations of therapeutic proteins to quickly be prepared for injection at high concentration and produces foam-free solutions that maximize the deliverable dose. CentuRecon is compatible with standard lyophilized formulations and diluents and with normal vials, cartridges, or dual-chamber syringes. It can be used for very high concentration and/or viscous solutions that may need to be delivered with injection devices.
Articles in this issue
about 12 years ago
The Importance of Continued Investment in R&Dabout 12 years ago
FDA Works to Secure Drug Supply Chainabout 12 years ago
Outsourcing Partnerships for CMC Developmentabout 12 years ago
MF40 Automated Punch and Die Polishing Machineabout 12 years ago
Quality by Design in APIsabout 12 years ago
Connecting People, Science, and Regulationabout 12 years ago
Effective and Efficient Weighing of Potent Compoundsabout 12 years ago
EU Raises API Standards: A Curse in Disguise?about 12 years ago
The Importance of Characterization in Biosimilars Developmentabout 12 years ago
Omega Design Corporation Introduces LabelSync 450Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.





